Karen Ferrante
Director/Board Member at MACROGENICS, INC.
Net worth: 40 964 $ as of 2024-03-30
Profile
Karen Jean Ferrante is an Independent Director at Cogent Biosciences, Inc. and MacroGenics, Inc. She is also a Director at New England Women In Science Executives Club.
Previously, she held positions as an Associate Director at Bristol Myers Squibb Co., an Independent Director at Progenics Pharmaceuticals, Inc., an Independent Non-Executive Director at HUTCHMED (China) Ltd., an Independent Director at Baxalta, Inc., and Vice President-Oncology Development at Pfizer Inc. She also served as the Head-Oncology Therapeutic Area at Millennium Pharmaceuticals, Inc. and as the Chief Medical Officer at Takeda Pharmaceutical Co., Ltd.
She was the Chief Medical Officer and Head-Research & Technology at Tokai Pharmaceuticals, Inc. Additionally, she held the position of Vice President-Oncology Department at Pfizer (St. Louis).
Dr. Ferrante received her undergraduate degree from Providence College and her doctorate degree from Georgetown University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
HUTCHMED (CHINA) LIMITED
0.00% | 2023-05-11 | 11,985 ( 0.00% ) | 40 964 $ | 2024-03-30 |
COGENT BIOSCIENCES, INC.
-.--% | 2024-03-31 | 0 ( -.--% ) | - $ | 2024-03-30 |
MACROGENICS, INC.
-.--% | 2023-05-30 | 0 ( -.--% ) | - $ | 2024-03-30 |
Karen Ferrante active positions
| Companies | Position | Start |
|---|---|---|
| MACROGENICS, INC. | Director/Board Member | 2017-01-24 |
| COGENT BIOSCIENCES, INC. | Director/Board Member | 2018-01-31 |
New England Women In Science Executives Club
 New England Women In Science Executives Club Miscellaneous Commercial ServicesCommercial Services The New England Women In Science Executives Club is a women's club that provides a platform for members to discuss their challenges, solutions, and ideas. The private company is based in Framingham, MA. | Director/Board Member | - |
Former positions of Karen Ferrante
| Companies | Position | End |
|---|---|---|
| HUTCHMED (CHINA) LIMITED | Director/Board Member | 2023-05-11 |
| PROGENICS PHARMACEUTICALS, INC. | Director/Board Member | 2020-06-18 |
Tokai Pharmaceuticals, Inc.
 Tokai Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tokai Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in developing novel proprietary therapies for the treatment of prostate cancer and hormonally driven diseases. The company was founded by Joseph A. Yanchik, Gregory L. Verdine, and Seth L. Harrison on March 26, 2004 and is headquartered in Boston, MA. | Chief Tech/Sci/R&D Officer | 2016-08-30 |
| BAXALTA INC | Director/Board Member | 2016-06-02 |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 2013-06-30 |
Training of Karen Ferrante
| Providence College | Undergraduate Degree |
| Georgetown University | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 6 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| PFIZER, INC. | Health Technology |
| HUTCHMED (CHINA) LIMITED | Health Technology |
| COGENT BIOSCIENCES, INC. | Health Technology |
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Health Technology |
| MACROGENICS, INC. | Health Technology |
| Private companies | 6 |
|---|---|
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Health Technology |
Progenics Pharmaceuticals, Inc.
 Progenics Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Progenics Pharmaceuticals, Inc. engages in the development of medicines and other products for targeting and treating cancer. Its pipeline includes therapeutic agents, imaging agents for prostate cancer, and imaging analysis technology. The company was founded by Paul J. Maddon on December 1, 1986 and is headquartered in New York, NY. | Health Technology |
Baxalta, Inc.
 Baxalta, Inc. BiotechnologyHealth Technology Baxalta, Inc. engages in the research, development, and manufacture of biopharmaceutical products. Its portfolio includes treatments for hemophilia, bleeding disorders, immune deficiencies, alpha-1 antitrypsin deficiency, burns, and shock. The company was founded on March 13, 2015 and is headquartered in Chicago, IL. | Health Technology |
Tokai Pharmaceuticals, Inc.
Tokai Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tokai Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in developing novel proprietary therapies for the treatment of prostate cancer and hormonally driven diseases. The company was founded by Joseph A. Yanchik, Gregory L. Verdine, and Seth L. Harrison on March 26, 2004 and is headquartered in Boston, MA. | Health Technology |
Pfizer (St. Louis)
 Pfizer (St. Louis) BiotechnologyHealth Technology Part of Pfizer Inc., Pfizer (St. Louis) is a private company that provides research services in prescription medicines for humans and animals. The company is based in Chesterfield, MO. | Health Technology |
New England Women In Science Executives Club
New England Women In Science Executives Club Miscellaneous Commercial ServicesCommercial Services The New England Women In Science Executives Club is a women's club that provides a platform for members to discuss their challenges, solutions, and ideas. The private company is based in Framingham, MA. | Commercial Services |
- Stock Market
- Insiders
- Karen Ferrante
